Home › Amgen, Inc. (AMGN) Upgraded at Morgan Stanley
 

Keywords :   


Amgen, Inc. (AMGN) Upgraded at Morgan Stanley

2015-12-15 02:20:07| Biotech - Topix.net

The firm currently has a $193.00 price target on the medical research company's stock, up from their previous price target of $160.00. Morgan Stanley's price objective indicates a potential upside of 22.07% from the company's previous close.

Tags: morgan stanley upgraded amgen

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »